Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Study provides a treasure trove of information on molecular biology of the immune system

Researchers at Sanford Burnham Prebys, collaborating with scientists from Eli Lilly and Company, have revealed the structure and function of a drug called LY3361237, which can reduce the harmful activity of the immune system to help treat autoimmune diseases.

5 Jun 2023

Unpacking the nutrient profiles of new-age plant-based foods: Are they truly healthier?

Concerns about the environment, ethics, and health drive the adoption of plant-based diets, but the healthiness of next-generation plant-based alternatives remains uncertain. Research explores the need to optimize nutrient profiles, digestibility, and bioavailability of plant-based foods for enhanced health benefits.

4 Jun 2023

Study offers the most comprehensive archive of cellular, molecular features involved in psoriatic disease

Beneath and beyond the reddish, flaky lesions that form in the skin of those with psoriasis, mild and severe forms of the disease can be told apart by the activity of key cells and signaling pathways, a new study shows.

2 Jun 2023

EULAR's new strategy for 2024 - 2028 announced

Over the period 2018 - 2023, EULAR, the leading organization in RMDs, has grown substantially and has been professionalized in every aspect.

2 Jun 2023

Study finds improved survival in patients with SLE-associated PAH

A team from Peking Union Medical College Hospital in Beijing, China, have explored changes in the characteristics, treatment, and 5-year survival for SLE-associated PAH in the last decade, and possible reasons for survival change.

2 Jun 2023

Understanding factors associated with long-term opioid use in fibromyalgia patients

Fibromyalgia is common, affecting around 2% of people in the general population. The 2017 EULAR recommendations state that tramadol - a weak opioid - may be considered for pain management in fibromyalgia, but advise against use of strong opioids due to lack of evidence of efficacy, and the high risk of side effects and addiction.

2 Jun 2023

Connecting patient organizations for the benefit of people with RMDs

RMDs are a burden for individuals, and a challenge to healthcare systems. There are not enough rheumatologists to look after the number of people with RMDs.

2 Jun 2023

Long-term side effects of modern treatment for rheumatoid arthritis

Janus kinase inhibitors (JAKi) and biologics are the cornerstone of modern treatment for rheumatoid arthritis (RA). But there have been concerns over long-term side effects.

1 Jun 2023

EULAR launches unique resource of facts and figures related to RMDs across Europe

The European Alliance of Associations for Rheumatology (EULAR) is proud to announce the launch of RheumaFacts, an innovative and unique resource of facts and figures related to rheumatic and musculoskeletal diseases (RMDs) across Europe.

1 Jun 2023

EULAR announces the launch of new survey targeted directly at RMD patients

The European Alliance of Associations for Rheumatology has announced the launch of the EULAR Impact of RMDs Survey, an online questionnaire targeted directly at RMD patients.

1 Jun 2023

Rheumatic and musculoskeletal diseases increase the risk of lethal comorbidities

Rheumatic and musculoskeletal diseases (RMDs) include over 200 diseases that affect over 120 million Europeans of all ages.

1 Jun 2023

Systematic approach needed to identify mental health issues in patients with inflammatory arthritis

Anxiety and depression are the mental health issues most commonly associated with inflammatory arthritis, and it is well-established that there is a link between mental health issues and poor health outcomes.

1 Jun 2023

Association between healthy lifestyle and mortality in people with osteoarthritis

In this work, data from the UK Biobank were used to investigate the association of both individual and combined healthy lifestyle factors with the risk of all-cause and cause-specific mortality among 104,142 people with osteoarthritis.

1 Jun 2023

Increased risk of cardiovascular disease in psoriatic arthritis patients

Patients with psoriatic arthritis (PsA) have an increased risk of cardiovascular disease, possibly due to a chronic inflammatory state.

1 Jun 2023

NIH scientists identify genomic variants that cause rare inflammatory skin disorder

Researchers at the National Institutes of Health and their colleagues have identified genomic variants that cause a rare and severe inflammatory skin disorder, known as disabling pansclerotic morphea, and have found a potential treatment.

31 May 2023

Personalized video exercises may be useful to support rehabilitation for people with RMD

Apps have become ubiquitous in many parts of life, including for health. For people with an RMD, personalized video exercises (PEV) may be useful to support rehabilitation and physical exercise.

31 May 2023

Breaking barriers to improve access to quality information about lupus

In general, there is an issue around the quality of information about lupus on the internet. Rumors, unchecked data, and unconfirmed research all contribute to confusion and anxiety, and can lead to people taking the wrong actions for themselves and their disease.

31 May 2023

Factors associated with diagnostic delay in Familial Mediterranean Fever

EULAR – The European Alliance of Associations for Rheumatology – held its 2023 annual congress in Milan, Italy. One of the abstracts chosen for presentation in the scientific session on Rheumatic and Musculoskeletal diseases (RMDs) in children and young people, focused on the factors associated with diagnostic delay in FMF, using data from the Juvenile Inflammatory Rheumatism (JIR) cohort.

31 May 2023

AI interpretations of MRI images could provide more accurate RA prediction

Early inflammatory arthritis is often undifferentiated, but it may develop into established RA or another arthropathy.

31 May 2023

Cardiovascular comobidities in RA patients

The increased cardiovascular risks in RA include acute coronary syndromes (ACS). The extent to which DMARD-induced remission could reduce the risk of ACS in RA versus rates in the general population – and whether there are DMARD-specific beneficial effects on ACS risk – remain unknown.

31 May 2023

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Study provides a treasure trove of information on molecular biology of the immune system

Unpacking the nutrient profiles of new-age plant-based foods: Are they truly healthier?

Study offers the most comprehensive archive of cellular, molecular features involved in psoriatic disease

EULAR's new strategy for 2024 - 2028 announced

Study finds improved survival in patients with SLE-associated PAH

Understanding factors associated with long-term opioid use in fibromyalgia patients

Connecting patient organizations for the benefit of people with RMDs

Long-term side effects of modern treatment for rheumatoid arthritis

EULAR launches unique resource of facts and figures related to RMDs across Europe

EULAR announces the launch of new survey targeted directly at RMD patients

Rheumatic and musculoskeletal diseases increase the risk of lethal comorbidities

Systematic approach needed to identify mental health issues in patients with inflammatory arthritis

Association between healthy lifestyle and mortality in people with osteoarthritis

Increased risk of cardiovascular disease in psoriatic arthritis patients

NIH scientists identify genomic variants that cause rare inflammatory skin disorder

Personalized video exercises may be useful to support rehabilitation for people with RMD

Breaking barriers to improve access to quality information about lupus

Factors associated with diagnostic delay in Familial Mediterranean Fever

AI interpretations of MRI images could provide more accurate RA prediction

Cardiovascular comobidities in RA patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in